Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-01

Clinical Trial Update: 24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring

View source ↗

Summary

A completed clinical trial evaluating 24-hour wear performance and safety of the miLens contact lens intended for intraocular pressure monitoring.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • miLens Contact Lens

Snippet

Sponsor: Smartlens, Inc. | Conditions: Glaucoma, GLAUCOMA 1, OPEN ANGLE, D (Disorder) | Status: COMPLETED